These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27273134)

  • 1. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
    Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
    J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
    Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
    Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients.
    Akasaka-Kihara F; Sueta D; Ishii M; Maki Y; Hirakawa K; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Hanatani S; Kanazawa H; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Kaikita K; Matsushita K; Matsuoka M; Usuku K; Tsujita K
    JACC Asia; 2021 Sep; 1(2):259-270. PubMed ID: 36338156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
    Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
    Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
    Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
    J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.
    Verzeroli C; Giaccherini C; Russo L; Bolognini S; Gamba S; Tartari CJ; Schieppati F; Ticozzi C; Vignoli A; Masci G; Sarmiento R; Spinelli D; Malighetti P; Tondini C; Petrelli F; Giuliani F; D'Alessio A; Gasparini G; Minelli M; De Braud F; Santoro A; Labianca R; Marchetti M; Falanga A;
    J Thromb Haemost; 2023 Jul; 21(7):1869-1881. PubMed ID: 37054917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment.
    Fuentes HE; Paz LH; Wang Y; Oramas DM; Simons CR; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):790-796. PubMed ID: 28884610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
    Li J; Yi J; Hua L; Su Y; Huo M; Dou F; Zhai Z; Zhu M; Zhang S; Zhang Y
    Thromb Res; 2021 Dec; 208():45-51. PubMed ID: 34695715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies.
    Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Umaña-Mora C; Céspedes-Calvo A; Mora-Hidalgo R
    Ecancermedicalscience; 2022; 16():1470. PubMed ID: 36819798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
    Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
    Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer.
    Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C
    J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy.
    Overvad TF; Ording AG; Nielsen PB; Skjøth F; Albertsen IE; Noble S; Vistisen AK; Gade IL; Severinsen MT; Piazza G; Larsen TB
    Blood Adv; 2022 May; 6(10):2967-2976. PubMed ID: 35045569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
    Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
    J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
    Hiraide M; Shiga T; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Yasuda C; Takahashi H; Hama T
    J Cardiol; 2020 Jan; 75(1):110-114. PubMed ID: 31416782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
    Li S; Gao P; Qiu J; He X; Mao Y
    J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma.
    Vathiotis I; Dimakakos EP; Boura P; Ntineri A; Charpidou A; Gerotziafas G; Syrigos K
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1347-1351. PubMed ID: 29806470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
    Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
    J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
    Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Newman P; Mortazavi R
    Thromb Res; 2024 Feb; 234():120-133. PubMed ID: 38215613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.